Growth Hormone (GH) Replacement Therapy in Adult-Onset GH Deficiency: Effects on Body Composition in Men and Women in a Double-Blind, Randomized, Placebo-Controlled Trial
Andrew R. Hoffman(Stanford University), Mary Lee Vance(University of Virginia), Janet Schlechte(University of Iowa), Michael O. Thorner(Ames National Laboratory), Howard B. A. Baum(Harvard University), Lawrence S. Phillips(Emory University), David L. Kleinberg(New York University), Richard V. Clark(Research Triangle Park Foundation), Richard J. Robbins(Cornell University), Beverly M. K. Biller(Massachusetts General Hospital), David M. Cook, E. Chester Ridgway(University of Colorado Denver), Gerhard Baumann(Northwestern University), Joyce Baptista, Anne Klibanski(Mass General Brigham), Silvio E. Inzucchi(Yale University), Meeta Sharma(George Washington University), Joyce Kuntze
Cited by 185
Related Papers
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
|New England Journal of Medicine|2015|11.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
|Diabetes Care|2012|3.2k
The Colorado Thyroid Disease Prevalence Study
|Archives of Internal Medicine|2000|2.8k